- Home
- WDI vs CRON Comparison
WDI vs CRON Comparison
Compare WDI & CRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WDI
- CRON
- Stock Information
- Founded
- WDI 2021
- CRON N/A
- Country
- WDI United States
- CRON Canada
- Employees
- WDI N/A
- CRON N/A
- Industry
- WDI Trusts Except Educational Religious and Charitable
- CRON Medicinal Chemicals and Botanical Products
- Sector
- WDI Finance
- CRON Health Care
- Exchange
- WDI Nasdaq
- CRON Nasdaq
- Market Cap
- WDI 753.0M
- CRON 684.7M
- IPO Year
- WDI N/A
- CRON N/A
- Fundamental
- Price
- WDI $14.79
- CRON $1.98
- Analyst Decision
- WDI
- CRON
- Analyst Count
- WDI 0
- CRON 0
- Target Price
- WDI N/A
- CRON N/A
- AVG Volume (30 Days)
- WDI 192.6K
- CRON 2.1M
- Earning Date
- WDI 01-01-0001
- CRON 05-08-2025
- Dividend Yield
- WDI 11.80%
- CRON N/A
- EPS Growth
- WDI N/A
- CRON N/A
- EPS
- WDI 1.12
- CRON 0.13
- Revenue
- WDI N/A
- CRON $124,589,000.00
- Revenue This Year
- WDI N/A
- CRON $25.49
- Revenue Next Year
- WDI N/A
- CRON $7.45
- P/E Ratio
- WDI $12.82
- CRON $15.35
- Revenue Growth
- WDI N/A
- CRON 33.92
- 52 Week Low
- WDI $12.16
- CRON $1.60
- 52 Week High
- WDI $14.69
- CRON $2.57
- Technical
- Relative Strength Index (RSI)
- WDI 68.11
- CRON 51.94
- Support Level
- WDI $14.50
- CRON $1.98
- Resistance Level
- WDI $14.90
- CRON $1.97
- Average True Range (ATR)
- WDI 0.15
- CRON 0.06
- MACD
- WDI 0.01
- CRON -0.02
- Stochastic Oscillator
- WDI 82.67
- CRON 29.17
About WDI Western Asset Diversified Income Fund of Beneficial Interest
Western Asset Diversified Income Fund is a newly-organized, diversified, closed-end management investment company. The fund's primary investment objective is to seek high current income.
About CRON Cronos Group Inc. Common Share
Cronos Group Inc headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the U.S., the company has an option to acquire 5.9% of U.S. multistate operator PharmaCann on a fully diluted basis upon easing of federal prohibition.